← Back to Search

Behavioural Intervention

Black Impact Intervention for Cardiovascular Health

N/A
Recruiting
Led By Joshua Joseph, MD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult age 18 years or older
Life's Essential 8 total average score < 80
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 156 weeks
Awards & highlights

Study Summary

This trial aims to develop a scalable intervention to improve cardiovascular health and psychosocial stress in Black men, to reduce CV disease risk. It will assess the efficacy of the intervention & evaluate the biological pathways.

Who is the study for?
This trial is for English-speaking Black men over 18 living in Metropolitan Columbus, Ohio, with below-average cardiovascular health as per the Life's Essential 8 score. It's not suitable for those who have been advised against physical activity by a healthcare provider.Check my eligibility
What is being tested?
The 'Black Impact' intervention is being tested to see if it can improve cardiovascular health and reduce psychosocial stress. Participants will engage in weekly physical activities, health education, and work with a health coach for 24 weeks.See study design
What are the potential side effects?
Since this intervention involves lifestyle changes like exercise and education rather than medication, side effects are minimal but may include typical exercise-related discomfort or injury.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My overall health score is below 80.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~156 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 156 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cardiovascular Health
Secondary outcome measures
Change in Central Aortic Pressure
Change in Conserved Transcriptional Response to Adversity
Change in Gut Microbiome Health
+18 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Black Impact InterventionExperimental Treatment1 Intervention
Black Impact Intervention
Group II: Black Impact Waitlist ControlActive Control1 Intervention
Usual Care

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
830 Previous Clinical Trials
505,280 Total Patients Enrolled
American Heart AssociationOTHER
326 Previous Clinical Trials
4,933,286 Total Patients Enrolled
Joshua Joseph, MDPrincipal InvestigatorOhio State University
1 Previous Clinical Trials
150 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants is the research team accepting for this trial?

"Aye, clinicaltrials.gov indicates that this medical trial is actively recruiting participants. The listing was initially posted on August 24th 2023 and revised most recently on September 19th 2023. 340 individuals are needed to be enrolled at one single site for the study's completion."

Answered by AI

Is there still an opportunity to participate in this experiment?

"Correct. According to clinicaltrials.gov, the commencement of this medical trial was on August 24th 2023 and is actively looking for 340 participants from a single centre. The research has been recently updated as well - September 19th 2023 being the most recent amendment date."

Answered by AI
~227 spots leftby Mar 2026